Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 12, pp. 1485-1495
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 6, 2020
- Revision received August 4, 2020
- Accepted September 29, 2020
- Published first October 2, 2020.
Article Versions
- Previous version (October 2, 2020 - 05:39).
- Previous version (November 5, 2020 - 05:54).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Anat Globerson Levin1,2,#,*,
- Moran Rawet Slobodkin1,#,
- Tova Waks1,2,
- Galit Horn1,
- Lihi Ninio-Many1,
- Naamit Deshet Unger1,
- Yaara Ohayon1,
- Shimrit Suliman1,
- Yael Cohen1,3,
- Boris Tartakovsky1,
- Ella Naparstek1,
- Irit Avivi1,3, and
- Zelig Eshhar1,2,3
- 1Tel Aviv Sourasky Medical Center (TASMC), Tel Aviv, Israel.
- 2Weizmann Institute of Science, Rehovot, Israel.
- 3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- ↵*Corresponding Author:
Anat Globerson Levin, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv 6423906, Israel. Phone: 972-3-6972503; Fax: 972-3-697-2549; E-mail: anatgl{at}tlvmc.gov.il
↵#Note: A. Globerson Levin and M. Rawet Slobodkin contributed equally to this article.
December 2020
Volume 8, Issue 12
Volume 8, Issue 12
Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity
Jump to section
Advertisement